Daily Stock List
Save the World Air, Inc. (ZERO)
Real Pennies reported today on Save the World Air, Inc. (ZERO), OTCPicks, AimHighProfits, StockGuru, StockHideout, PennyTrader Publisher, Penny Stock Rumble did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Save the World Air, Inc. (STWA) is a developer of applied solutions for oil and fuel delivery systems. The Company develops and commercializes energy efficiency technologies that assist in meeting increasing worldwide energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. STWA's intellectual property (IP) portfolio includes domestic and international patents and patents pending. These have undergone development together with and exclusively licensed from Temple University.
The Company's technologies include Applied Oil Technology™ (AOT™), designed to improve oil flow through pipelines. AOT™ has been proven in U.S. Department of Energy tests to increase the energy efficiency of oil pipeline pump stations. The design of the AOT Enhanced Oil Transport System is to be installed to existing and new build pipelines. The purpose behind the system is to provide a way for the pipeline operator to reduce their operational expenses instantly. This is while allowing the pipeline operator's customers to increase the number of barrels they can move through that pipeline daily. Furthermore, ELEKTRA™ improves diesel engine efficiency for industrial diesel engines and diesel-powered trucks, trains, marine vessels, military fleets and jet turbines.
Recently, STWA announced that Montana State Senator Ryan Zinke joined their Board of Directors. The Company's Applied Oil Technology™ (AOT™) oil pipeline efficiency technology supports Senator Zinke's platform of moving the U.S. towards energy independence. Senator Zinke and STWA President and CFO, Gregg Bigger, have been travelling over the past few months introducing various members of the North American energy industry to AOT™. This is part of Senator Zinke's efforts to enable further growth in domestic energy production.
In addition, recently, STWA announced that they continue to build their (IP) portfolio surrounding their corporate assets. The Company has increased their IP portfolio to include 41 patents issued and pending that protect their products across 20 countries, based on technologies licensed exclusively from Temple University.
Save the World Air, Inc. (ZERO), closed Wednesday's trading session at $0.99, up 1.02%, on 277,189 volume with 110 trades. The average volume for the last 60 days is 308,976 and the stock's 52-week low/high is $0.27/$1.92.
Hangover Joe's Holding Corp. (HJOE)
We are highlighting Hangover Joe's Holding Corp. (HJOE), here at the QualityStocks Daily Newsletter.
Incorporated in 2012, Hangover Joe's develops and manufactures alcohol recovery shots. The Company offers their products via stores in the U.S., Canada, and worldwide. They are the exclusive producer of The Hangover Recovery Shot, the official licensed product of The Hangover movie and the nation's Number One selling hangover recovery product. Hangover Joe's Holding has their headquarters in Colorado Springs, Colorado. On July 25, 2012, Hangover Joe's became a publicly traded company and lists on the OTC Bulletin Board.
Hangover Joe's Recovery Shot quickly puts back some of the key ingredients necessary to relieve a hangover and promote recovery. The product consists of the freshest, most pure ingredients. It is easy to use and convenient to carry around. Hangover Joe's is a patent pending product and is the only morning after hangover recovery shot on the market to counteract the symptoms of a hangover. A laboratory chemist who is an expert in the field formulated the product. The design of Hangover Joe's is for those who like to enjoy alcohol responsibly, without the unpleasant side effects of a hangover.
Hangover Joe's Recovery Shot is for overcoming the day-after side effects of alcohol consumption. Taken the morning after, it features a patent-pending blend of antioxidants, vitamins and herbs. In 2012, Hangover Joe's experienced a 200 percent growth in sales from 2011. The brand also began international distribution, shipping product to Canada, Australia and New Zealand. Hangover Joe's was recently awarded 'Best New Shot of 2012' by CSN Magazine.
Hangover Joe's Recovery Shot can be bought coast-to-coast in the United States. This includes at retail outlets such as 7-11, Racetrac, Love Truck Stops, Valero, Terrible Herbst gas stations, Aloha Gas, Long's Drugs, Kwik Shops, and select Bed, Bath & Beyond outlets, Stripes Convenience Stores and Hastings Entertainment. The product can also be purchased at MGM Resorts and Harrah's.
Recently, Hangover Joe's Holding announced a number of new distribution agreements as well as the addition of several new retail programs across the United States. The Company recently signed a new distribution deal with Starco Impex, Inc. Starco is a major distributor to convenience and tobacco stores. In addition, the Company signed a distribution agreement with Bebida Beverage Co., a premium distributor in the New York metropolitan area.
Hangover Joe's Holding Corp. (HJOE), closed Wednesday's trading session at $0.10, up 33.33%, on 29,630 volume with 9 trades. The average volume for the last 60 days is 12,444 and the stock's 52-week low/high is $0.04/$0.59.
Southern Products, Inc. (SNPD)
SmallCapVoice reported earlier on Southern Products, Inc. (SNPD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Southern Products, Inc. is a consumer electronics company whose shares trade on the OTC Bulletin Board. The Company engages in the design, assembly, import, marketing, and sale of flat panel televisions under the Sigmac brand name. Southern Products distributes flat-panel televisions and peripherals via big-box retailers in the United States. Incorporated in the State of Nevada, the Company is based in City of Industry, California.
Founded in 2010, Southern Products has a product line of 21 flat-panel models in production. The Company has distribution agreements with Fry's Electronics, Target, Costco, Tiger Direct, and Walmart for the sale of Sigmac-branded flat-panel televisions and peripherals in North America. Southern Products' mission is to establish an internationally recognized line of consumer electronic products.
For Light-Emitting Diode (LED) products, the Company offers their LE55ABD1, LE55ABD, LE42AB1, and SE42AB products. The LE55ABD1 product offers a 3D entertainment experience. It has a screen size of 54.65 inches. The LE55ABD product enables users to enjoy movies, video games and more in 3D. The LE42AB1 offering is an LED TV suited to fit into one's office or dorm room, as is the SE42AB product. The Company also has additional product offerings in the LED category.
Concerning Liquid Crystal Display (LCD) products, the Company offers NE42AB – for watching movies and TV shows in HD quality with 1080p and 3 HDMI inputs. This product mounts on a stand or on a wall. The screen size of the NE42AB product is 42.00 inches.
Their NE32AB1 TV produces a native 1080p HD resolution displaying clear crisp HD images with multiple video inputs, including 3 HDMI connections. Their SC39AB product offers high-level video and audio entertainment. The screen size of this particular product offering is 38.50 inches. Moreover, the Company's SC32AB LCD HDTV has multiple video inputs, including 3 HDMI connections. A user can be flexible in connecting their existing multimedia components.
Southern Products, Inc. (SNPD), closed Wednesday's trading session at $0.40, up 81.82%, on 4,830 volume with 5 trades. The average volume for the last 60 days is 993 and the stock's 52-week low/high is $1.00/$5.00.
Vanstar Mining Resources, Inc. (VSR.V)
Today we are highlighting Vanstar Mining Resources, Inc. (VSR.V), here at the QualityStocks Daily Newsletter.
Vanstar Mining Resources, Inc. engages in the acquisition, exploration, production, development and operation of mining properties. The Company operates in Quebec, one of Canada's richest mining provinces. Vanstar holds a portfolio of mining properties, with more than 10,000 hectares with strong potential for Gold, Silver, Copper, and Zinc. Incorporated in 2007, Vanstar Mining Resources' shares trade on the TSX Venture exchange and the Company has their corporate headquarters in La Prairie, Quebec.
Concerning projects in development, the Company has their Nelligan Property. This property is 100 percent owned by Vanstar – 2 percent royalty (on 12 original cells). The property is 92 cells and more than 4,968 hectares. The geological and structural environment is favorable to the presence of Archean mesothermal gold mineralization of vein and replacement types.
Philibert-Gold mineralization is linked to a white-smoky quartz vein with tourmaline, carbonate and lightly mineralized with pyrite. Gold appears more abundant where the quartz vein contains tourmaline and/or pyrite. The Nelligan property is similar to the Joe Mann mine (3.35m at 9.1g/t), the Philibert deposit (1.5m at 5.4g/t) and the Chevrier deposit (1.8m at 5.1g/t).
Vanstar also has their Little Monster project. The Little Monster Property consists of 20 map-designated claims, totaling 1,040 hectares, located in the Southeastern band of the Fancamp Deformation Zone (FDZ) in the volcanic zone of the Abitibi SubProvince in the Roy Group. Most structures intersecting with the Fancamp Deformation Zone represent high potential targets for gold mineralization exploration.
The project is held in equal proportions by Vanstar Resources and Northcore Resources, Inc. Vanstar is the project manager. The 20-kilometer long Fancamp Deformation Zone is host to a number of gold deposits and occurrences.
In September 2012, Vanstar Mining Resources announced the completion of a second drilling campaign on the Nelligan project, located in the Chapais-Chibougamau area. They said the drilling program did not outline a sector with economical gold grades, despite a constant occurrence of gold in most drill holes. The Nelligan showing, consisting of zone A and B, is now known on more than 600 meters and remains open in-depth and in its lateral extensions.
Vanstar Mining Resources, Inc. (VSR.V), closed Wednesday's trading session at $0.095, up 46.15%, on 3,000 volume. The stock's 52-week low/high is $0.06/$0.19.
American Bonanza Gold Corp. (ABGFF)
We are reporting on American Bonanza Gold Corp. (ABGFF) today, here at the QualityStocks Daily Newsletter.
Listed on the OTCQX International, American Bonanza Gold Corp. explores and develops gold mining projects in pro-mining areas of the U.S. and Canada. The Company is operating the newly constructed Copperstone gold mine in Arizona. The Copperstone property contains a 10.3 g/t oxide gold resource with 313,000 ounces of gold in the Measured and Indicated categories and 256,000 ounces of gold in the Proven and Probable Mineral Reserves category.
The Company announced in December, that during November 2012, ore was available for mining in five zones at the Copperstone property - up from three zones during October 2012. The Company states that this is a significant achievement towards bringing mine output to design levels of 450 tons per day of ore. The five zones are developed; access, power distribution, and water management is being maintained as development mining continues to improve. The main objective for the development-mining program is currently to provide access to one or two additional zones over the next month.
American Bonanza Gold is encouraged with the recent progress as the Company continues towards their goal of achieving commercial production, estimated for the first quarter of 2013. Due to the development mining accelerating, ore extraction rates improved during November and continued to improve during December.
Total rock mined during November averaged 605 tons per day, and ore mined averaged 269 tons per day, with development mining averaging 337 tons per day. Ore tonnage processed through the gold plant during November was steady relative to performance in October. Ore processed during November averaged 351 tons per day - 360 tons per day in October. Mine and mill performance, for the full month of December 2012, will be announced during mid-January 2013.
Bonanza announced in December that they completed on schedule the repayment of the secured gold prepayment facility with Resource Income Fund, L.P. (RIF). Bonanza sold 3,936 ounces of gold for delivery during 2012 (the Facility). The Facility was a forward contract structured to deliver 3,936 ounces of gold over a 32-week term for 123 ounces per week starting on May 7, 2012 and ending on December 10, 2012. The 3,936 ounces of gold that were committed under this gold facility represent approximately 1.5 percent of the proven mineral reserves at the Copperstone gold mine.
American Bonanza Gold Corp. (ABGFF), closed Wednesday's trading session at $0.1586, up 5.03%, on 17,000 volume with 4 trades. The average volume for the last 60 days is 36,707 and the stock's 52-week low/high is $0.13/$0.593.
Cord Blood America, Inc. (CBAI)
OTCPicks, StreetInsider, Greenbackers, MoneyTV, PennyTrader Publisher, and SmallCapVoice reported earlier on Cord Blood America, Inc. (CBAI), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. that facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Through the wholly owned CorCell Companies, Cord Blood America engages in the business of collecting, testing, processing and preserving umbilical cord blood. This allows families to preserve cord blood at the birth of a child for potential use in future stem cell therapy. Cord Blood America lists on the OTC Bulletin Board. The Company has their corporate headquarters in Las Vegas, Nevada.
Cord Blood America's mission is to become the most respected, globally dominant stem cell storage company. In January 2003, the Company's original stem cell storage company, Cord Partners, Inc., launched. In January 2005, Cord Partners reverse merged into Cord Blood America and began trading on the OTCBB.
Cord Blood America offers Professional Services. They offer processing and storage services for use by other cord blood banking brands. The Company provides customized cord blood processing solutions using a non-automated processing technique. They are licensed in New Jersey, New York, California and Maryland; they are also registered with the FDA. In addition, the Company is a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory.
Recently, Cord Blood America announced financial results for the three and nine months periods ended September 30, 2012. Third Quarter 2012 highlights include Revenue increasing 14 percent to $1.51 million from $1.33 million in the prior year period. Recurring revenue increased 13 percent to $698,103. Administrative and selling expenses decreased 14 percent to $1.09 million from $1.22 million in the prior year period. EBITDA was $166,841, in comparison to a loss of $206,949 in the prior year period.
For the nine-months, ended September 30, 2012, highlights include Revenue increasing 18 percent to $4.64 million from $3.93 million in the year ago period. The Company's cash position increased more than 100 percent to $369,186. Gross margin increased to 72.7 percent from 70.5 percent in the year ago period. Selling, General & Administrative Expenses decreased 24 percent or $1.17 million to $3.64 million from $4.81 million.
Cord Blood America, Inc. (CBAI), closed Wednesday's trading session at $0.0054, up 8.00%, on 5,110,700 volume with 58 trades. The average volume for the last 60 days is 4,733,433 and the stock's 52-week low/high is $0.0021/$0.0451.
Rio Novo Gold, Inc. (RN.TO)
MarketGainer and Super Stock Picker reported previously on Rio Novo Gold, Inc. (RN.TO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Rio Novo Gold, Inc. involves in the acquisition, exploration, and development of mineral resource properties. The Company mainly explores for gold deposits. They formerly went by the name Rio Novo Holdings S.A. They changed their corporate name to Rio Novo Gold Inc. in January of 2010. The Company's shares trade on the Toronto Stock Exchange. Rio Novo Gold has their headquarters in Toronto, Ontario.
The Company is focusing on the acquisition, exploration and development of gold properties in Brazil and Colombia. Rio Novo Gold has Measured & Indicated resources of 1,191,252 oz and 1,464,831 Inferred oz of gold at two projects in Brazil (Almas and Guarantã Gold Projects) and one in Colombia (Toldafria Gold Project).
Their short-term goal is to become a producer of gold by bringing the Almas Gold Project, located in the State of Tocantins, into production in 2014. The Almas Project has established infrastructure and main grid hydropower in a proven and mining friendly jurisdiction. Additionally, it has permitting for construction.
Recently, Rio Novo Gold announced that there would be a delay in filing the NI 43-101 Technical Report related to the Feasibility Study for the Company's 100 percent-owned Almas Gold Project in Brazil. Pursuant to National Instrument 43-101 "Standards of Disclosure for Mineral Projects", the Technical Report must be filed on or before December 23, 2012, 45 days from the date of the announcement of the completion of the Feasibility Study, which occurred on November 8, 2012.
The Feasibility Study is being compiled by RungePincockMinarco, Rio Novo's independent engineering consultant, in compliance with NI 43-101 requirements. The Company anticipates that the Technical Report will be completed this month.
During the three months ended September 30, 2012, Rio Novo Gold incurred a net loss of US$ 311,150 (US$0.00 per share) compared to a net loss of US$ 565,890 (US$0.00 per share) in the corresponding period of 2011. As at September 30, 2012, the Company had working capital of US$ 9,198,315 and a net cash position of $10,033,642.
Rio Novo Gold, Inc. (RN.TO), closed Wednesday's trading session at $0.18, up 9.09%, on 48,800 volume. The stock's 52-week low/high is $0.16/$0.97.
Graymark Healthcare, Inc. (GRMH)
StreetInsider, OTCPicks, SmallCap Voice, Daily Markets, and PennyOmega reported earlier on Graymark Healthcare, Inc. (GRMH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Graymark Healthcare, Inc. is one of the largest providers of care management solutions to the sleep disorder market based on number of independent sleep care centers and hospital sleep diagnostic programs operated in the U.S. The Company diagnoses and treats more than 80 sleep disorders. Additionally, they specialize in complete care for Obstructive Sleep Apnea (OSA). Graymark also sells equipment and related supplies and components used to treat sleep disorders. Graymark Healthcare is based in Oklahoma City, Oklahoma; the Company lists on the OTC Market's OTCQB.
As of September 30, 2012, Graymark Healthcare operated 107 sleep diagnostic and therapy centers in 10 states; 26 are located in their facilities, with the remaining centers operated under management agreements. There are certain non-controlling interest holders in some of the Company's testing facilities, who are usually physicians in the geographical area being served by the diagnostic sleep testing facility. Graymark offers their services through sleep laboratories primarily in the Midwest. These include standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements.
Five key elements support Graymark Healthcare's clinical approach. One element is Referrals; their medical directors (board-certified physicians in sleep medicine) have established strong relationships with referral sources. These include primary care physicians and physicians from a broad array of other specialties, and dentists.
The second is Diagnosis. The Company owns and operates sleep testing clinics that diagnose the full range of sleep disorders. These include OSA, insomnia, narcolepsy and restless legs syndrome. The third element is CPAP Device Supply. Graymark sells CPAP devices used to treat OSA.
The fourth element is Re-Supply. The Company offers a re-supply program for their patients and other CPAP users to obtain the required disposable components for their CPAP devices that must undergo replacement on a regular basis. The fifth element is Care Management. They provide continuing care to their patients led by their medical directors and their staff.
In November, Graymark Healthcare reported financial results for the third quarter ended September 30, 2012. Net revenues in the third quarter of 2012 were $4.3 million, decreasing 4.3 percent from $4.5 million in the third quarter of 2011. Loss from continuing operations, net of taxes, were $2.0 million for the third quarter of 2012, compared to a loss from continuing operations of $1.6 million in the prior year quarter. Net loss attributable to the Company was $2.2 million or $(0.15) per share in the third quarter of 2012, compared to a net loss of $1.6 million or $(0.10) per share in the prior year quarter.
Graymark Healthcare, Inc. (GRMH), closed Wednesday's trading session at $0.225, even for the day, on 1,000 volume with 1 trade. The average volume for the last 60 days is 2,228 and the stock's 52-week low/high is $0.15/$0.50.
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.012, even with yesterday's close, on 748,371 volume with 17 trades. The stock’s average daily volume over the past 60 days is 1,267,242, and its 52-week low/high is $0.0013/$0.015.
VIASPACE, Inc. announced that the company's CEO, the esteemed Dr. Carl Kukkonen, has been invited to make a presentation at the 2013 Energy, Utility and Environment Conference (EUEC) in Phoenix, Arizona, this Tuesday, January 29. Dr. Kukkonen will deliver a tour de force presentation on "Giant King™ Grass as an Energy Crop in the United States," detailing the benefits of this low-carbon feedstock for clean energy generation. VIASPACE will also be exhibiting at booth #734 in the main hall, with a full display of this revolutionary, 17-foot tall marvel that promises to transform the face of green cellulosic biofuels, biochemicals, and biomaterials.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE CEO Invited to Speak At EUEC2013 Conference and Company to Feature GiantKing™ Grass in Exhibit Hall
St. Croix Giant King Grass-Fueled Electric Power Plant Design Approved by Public Services Commission
VIASPACE Chairman Interviews With WallStreetReporter and Provides Commentary
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $8.80, up 9.73%, on 64,593 volume with 162 trades. The stock’s average daily volume over the past 60 days is 31,615, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
Umbrella Research Initiates Coverage on TNI BioTech
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.1925, up 1.32%, on 182,894 volume with 163 trades. The stock’s average daily volume over the past 60 days is 199,098, and its 52-week low/high is $0.17/$0.42.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium Announces Patent Award For Rights To Gene Therapy for Coronary Heart Disease, Resolves Long-standing IP Competition
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.20, even for the day, on 32,166 volume with 15 trades. The stock’s average daily volume over the past 60 days is 133,729, and its 52-week low/high is $0.161/$0.68.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
Lifeline Skin Care a Subsidiary of ISCO Announces New Sales and Multi-Media Marketing Campaigns
German Court Decision May Strengthen International Stem Cell Corporation's Position in European Market
International Stem Cell Corp to Participate in Fifth Annual LD Micro Conference
Today, shortly before the opening bell, VIASPACE announced that its CEO, Dr. Carl Kukkonen, will make an invited presentation at the 2013 Energy, Utility, and Environment Conference (EUEC) in Phoenix, Arizona, on Tuesday, January 29, 2013.
Dr. Kukkonen’s presentation on Giant King Grass (GKG) and its energy crop applications will be delivered at 3:30PM in the Phoenix Convention Center North. VIASPACE is also an exhibiting company and will be displaying its proprietary, 17 feet tall GKG live at booth #734 in the exhibition hall.
The USA’s largest, longest-running, professional networking and educational event of its kind, EUEC will be hosting its 16th annual conference this year. Environmental business leaders, energy executives, and government policy makers give presentations and discuss various issues in a 12-track program. The EUEC motivates clean renewable and alternate energy solutions to secure energy independence from foreign oil, while protecting the environment. More than 600 presentations are made by experts during the conference covering diverse topics of clean air policy, legislation and green technologies, energy and climate policy, wind power, solar power, carbon markets, corporate greenhouse gas strategies, biofuels, biomass, biogas, and renewable energy management.
Dr. Carl Kukkonen stated, “Not only will my invited presentation focus on the economic and environmental benefits of using Giant King Grass as a dedicated energy crop in the Southern United States, Puerto Rico and Hawaii, we will for the first time be displaying live, mature Giant King Grass in our exhibition booth. Potential customers, conference attendees, investors and other interested parties will be able to see GKG firsthand. Giant King Grass is an impressive bioenergy product when seen and experienced in person. I am also pleased to announce that our Chairman, Dr. Schewe, will be attending the conference with me and will assist in meeting with various clients, interested parties, investors and will participate with me in our Q & A session on Monday evening.”
“Last year at EUEC2012, 2,037 delegates attended this conference and this year the U.S. Department of Energy is a Silver Level Exhibitor,” VIASPACE Chairman Dr. Kevin Schewe added. “Dr. Kukkonen is speaking in the ‘Cofiring in Power Plants’ track and we will have live, mature Giant King Grass in our exhibition booth along with samples of GKG pellets to show prospective clients and partners. With GKG recently being granted USDA approval in the U.S., we will use this opportunity to effectively network and expand our Company name recognition and presence in the U.S. marketplace. We have been very busy at the end of 2012 harvesting and shipping GKG seedlings from our California site and look forward to soon announcing the new locations and projects that we are actively pursuing.”
VIASPACE told investors that it has 10 free passes for guests who wish to visit the company’s booth during the Monday evening reception from 4:00 to 7:00PM. Dr. Kukkonen and Dr. Schewe will be available for questions. Interested parties should email Jaclyn Kenner at email@example.com. Those who want to attend the entire day (either January 28 or January 29, 2013) can purchase a pro-rated ticket for $395 in advance or at the convention. Ms. Kenner will be coordinating activities at the exhibit booth and keep investors informed via Facebook, Twitter, and LinkedIn during the conference.
For more information on VIASPACE and its energy crop, visit www.VIASPACE.com
It has been estimated that the global cloud computing industry could be worth nearly a quarter of a trillion dollars by the end of the current decade, with cloud storage playing a major role in that growth. The overall benefits of cloud storage and processing are increasingly well known: Cloud computing reduces up-front investment in hardware and software; it provides flexible levels of storage and service as your business requirements change; it offers tremendous flexibility for data access, especially important for companies with scattered facilities and mobile employees. However, for small businesses that have yet to tap into the cloud, concerns about data security often obscure important advantages of the cloud when it comes to natural or manmade disasters.
Cloud computing, first and foremost, can provide a disaster recovery capability far in excess of what many small businesses can themselves afford to put together. The scale of affordable security and recovery capabilities available on the cloud is greater than on-site options for small companies. The pay-as-needed environment of the cloud can make even the most sophisticated recovery plans viable. Cloud based disaster recovery, now becoming a separate aspect in its own right, offers dependable business continuity, through greater assurance of data and processing survival. Users can, for example, easily disperse data over multiple geographically separated data centers if needed.
Hurricane Sandy was one of the first major tests of cloud operation in the face of a widespread disaster. Some data centers were indeed damaged or lost power, but were often quickly brought back online with battery backup. The bigger issue turned out to be the loss of power of users, which would affect both in-house and cloud operations.
In the case of GlobalWise Investments, and its Intellivue subsidiary, providers of Enterprise Content Management (ECM) as a cloud based solution for document management, clients are dealing with critical documents, often public and legal documents, for which secure recovery is a key priority. Clients can require rapid access, covering large document databases, on a 24/7 basis, from virtually anywhere in the world, and can’t afford to have weather or other disasters threaten daily operations. The diversity of the GlobalWise customer base is a testament to the company’s ability to satisfy a wide range of disaster recovery and security needs.
For additional information, visit www.GlobalWiseInvestments.com
Petaquilla Minerals has received and accepted from Red Kite Mine Finance Trust I (the lender) an indicative term sheet for a loan facility, in which the lender has offered to provide Petaquilla with a loan facility for an aggregate $140 million to develop, construct, and meet working capital requirements for its projects in Panama and Iberia.
Closing of the loan facility is expected to take place on or near Jan. 15 and is subject to customary due diligence, regulatory approvals, and final legal documentation that reflects the terms of the term sheet.
Upon closing, an initial tranche of $90 million will be available to Petaquilla, and the remaining $50 million will be released based on technical milestones – namely, updated National Instrument 43-101 resource estimates on either of Petaquilla’s two projects.
Using the initial $90 million, Petaquilla will be able to, among other things, proceed with the payout of its existing gold and silver prepayment contracts and convertible loan with the London Branch of Deutsche Bank AG, which will effectively free an average of 1,500 gold ounces per month, or around $30 million annual cash flow currently committed to such contracts. The Deutsche Bank payout will additionally free Panama Desarrollo de Infraestructuras, S.A., the company’s infrastructure division, for spinout to shareholders during the first calendar quarter of 2013.
In addition to the annual cash flows resulting from the payout of the gold and silver prepayment contracts, the net proceeds from the loan will also allow Petaquilla to bring the Lomero-Poyatos project to its initial onsite production by the middle of 2014.
Petaquilla Minerals is a growing diversified gold producer focused on maximizing shareholder value through a strategy of efficient production, targeted exploration, and select acquisitions. The company operates a surface gold processing plant at its Molejon Gold Project, located in the south central area of Panama – a region known historically for gold content. In addition, Petaquilla has exploration operations at its wholly-owned Lomero-Poyatos project, located in the northeast part of the Spanish/Portuguese (Iberian) Pyrite Belt, and several other exploration licenses in Iberia.
For more information, visit www.petaquilla.com
SORL Auto Parts, a leading supplier of brake and control systems to the global commercial vehicle industry, recently announced that the Chinese government renewed its status as a High-Tech Enterprise. SORL will receive a preferred tax rate of 15% for three fiscal years, compared with the normal 25% corporate tax rate.
• Own proprietary intellectual rights
• Operate in a government-selected industry
• R&D expenditures and income from high-tech products/services each must meet a required minimum percentage of annual revenue
• The number of R&D personnel must meet a required percentage of total employees
SORL has received its anticipated tax refund for the first three quarters of 2012 of approximately $1.2 million (approximately RMB 7.64 million) resulting from this designation.
Ms. Jinrui Yu, SORL Auto Parts’ COO, said, “The High-Tech Enterprise designation reflects the Chinese government’s desire to build the domestic technology base by favoring only companies that are advancing technologies. Our research and development program is innovating new products with higher technology content to offer better solutions for our customers’ current vehicles and to prepare for future vehicles, especially pure electric and plug-in hybrid vehicles promoted by the Chinese government. Innovation will enable us to sustain our leading position in the domestic market for brake systems and better penetrate the global auto parts industry to gain momentum for our future growth, strengthen our technology base and build shareholder value.”
For fiscal year 2012, management stated expectations for net sales to be approximately $191.4 million and revised its net income expectation to be approximately $12.7 million. The revised net income guidance is based upon the preferred 15% tax rate from the renewal of the High-Tech Enterprise status.
As the market leader for commercial vehicles brake systems, such as trucks and buses in China, SORL Auto Parts distributes products within China and internationally under the SORL trademark. SORL is listed among the top 100 auto component suppliers in China, and has a product range that includes 65 categories with over 2,000 specifications in brake systems and others. SORL is working to establish a broader global sales network and currently has four authorized international sales centers in UAE, India, the United States, and Europe.
For more information, please visit www.sorl.cn
Today's Top 3
The QualityStocks Public Company Sponsor News